Joanna Obacz
Titre
Citée par
Citée par
Année
Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives
J Obacz, T Avril, PJ Le Reste, H Urra, V Quillien, C Hetz, E Chevet
Science signaling 10 (470), 2017
762017
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
SE Logue, EP McGrath, P Cleary, S Greene, K Mnich, A Almanza, ...
Nature communications 9 (1), 1-14, 2018
632018
Dual IRE 1 RN ase functions dictate glioblastoma development
S Lhomond, T Avril, N Dejeans, K Voutetakis, D Doultsinos, M McMahon, ...
EMBO molecular medicine 10 (3), e7929, 2018
612018
Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
J Obacz, S Pastorekova, B Vojtesek, R Hrstka
Molecular cancer 12 (1), 1-10, 2013
602013
The role of AGR2 and AGR3 in cancer: similar but not identical
J Obacz, M Takacova, V Brychtova, P Dobes, S Pastorekova, B Vojtesek, ...
European journal of cell biology 94 (3-4), 139-147, 2015
372015
CD90 expression controls migration and predicts dasatinib response in glioblastoma
T Avril, A Etcheverry, R Pineau, J Obacz, G Jegou, F Jouan, PJ Le Reste, ...
Clinical Cancer Research 23 (23), 7360-7374, 2017
202017
Regulation of tumor–stroma interactions by the unfolded protein response
J Obacz, T Avril, C Rubio‐Patiño, JP Bossowski, A Igbaria, JE Ricci, ...
The FEBS Journal 286 (2), 279-296, 2019
172019
Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells
R Hrstka, J Podhorec, R Nenutil, L Sommerova, J Obacz, M Durech, ...
Cancer Investigation 35 (5), 313-324, 2017
152017
Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients
J Obacz, V Brychtova, J Podhorec, P Fabian, P Dobes, B Vojtesek, ...
OncoTargets and therapy 8, 1523, 2015
152015
Control of anterior GR adient 2 (AGR 2) dimerization links endoplasmic reticulum proteostasis to inflammation
M Maurel, J Obacz, T Avril, YP Ding, O Papadodima, X Treton, F Daniel, ...
EMBO molecular medicine 11 (6), e10120, 2019
82019
Extracellular AGR3 regulates breast cancer cells migration via Src signaling
J Obacz, L Sommerova, D Sicari, M Durech, T Avril, F Iuliano, ...
Oncology letters 18 (5), 4449-4456, 2019
32019
Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells
J Obacz, J Archambeau, D Sicari, PJ Le Reste, R Pineau, S Martin, ...
bioRxiv, 533018, 2020
2020
Constitutive UPRER activation sustains tumor cell differentiation
D Doultsinos, M McMahon, K Voutetakis, J Obacz, R Pineau, PJ Le Reste, ...
bioRxiv, 594630, 2019
2019
Control of glioblastoma differentiated-to-stem cell reprogramming by IRElα/XBPls signaling
D Doultsinos, M McMahon, K Voutetakis, J Obacz, R Pineau, F Jouan, ...
bioRxiv, 594630, 2019
2019
Constitutive IRE1α signaling maintains glioblastoma cell differentiation state
D Doultsinos, M McMahon, K Voutetakis, J Obacz, R Pineau, F Jouan, ...
bioRxiv, 594630, 2019
2019
IRE1-UBE2D3 signaling controls the recruitment of myeloid cells to glioblastoma
J Obacz, J Archambeau, PJ Le Reste, R Pineau, F Jouan, K Barroso, ...
bioRxiv, 533018, 2019
2019
Karcinom dutiny ústní–nové prognostické faktory?
J Blahák, V Brychtová, J Obacz, J Zelinka, P Fabian, R Hrstka, ...
2016
ANTERIOR GRADIENT PROTEIN 3 (AGR3) IS ASSOCIATED WITH LESS AGGRESSIVE TUMOURS AND BETTER OUTCOME OF BREAST CANCER PATIENTS
JA Obacz, V Brychtová, J Podhorec, P Fabian, P Dobeš, B Vojtěšek, ...
2015
Zhodnocení exprese proteinů AGR2, AGR3 a MUC4 u karcinomu dutiny ústní
V Brychtová, J Blahák, J Obacz, J Zelinka, P Fabián, R Hrstka, ...
2014
Investigation of AGR3 protein function and mechanisms triggering its expression in cancer cell
J Obacz
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20